microbiome

Developing a range of products to modify the human
microbiome and bring specific health benefits

RNS & Investor News

Holding(s) in Company

24 March 2017

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
   
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii OptiBiotix Health Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached  
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments  
An event changing the breakdown of voting rights  
Other (please specify):    
3. Full name of person(s) subject to the notification obligation: iii Finance Yorkshire Seedcorn Fund (FYSCF)
4. Full name of shareholder(s) (if different from 3.):iv  
5. Date of the transaction and date on which the threshold is crossed or reached: v 06 March 2017
6. Date on which issuer notified: 10 March 2017
7. Threshold(s) that is/are crossed or reached: vi, vii 14%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares

if possible using the ISIN CODE
Situation previous to the triggering transaction Resulting situation after the triggering transaction
Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights x
Direct Direct xi Indirectxii Direct Indirect
GB00BP0RTP38 11,999,314 11,999,314 10,499,314 10,499,314 Nil 13.40 Nil
 
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date xiii Exercise/Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
None        
 
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
None         Nominal Delta
   
 
Total (A+B+C)
Number of voting rights Percentage of voting rights
10,499,314 13.40%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi
 
 
Proxy Voting:
10. Name of the proxy holder:  
11. Number of voting rights proxy holder will cease to hold:  
12. Date on which proxy holder will cease to hold voting rights:  
 
13. Additional information:  
14. Contact name: Enterprise Ventures Limited
15. Contact telephone number: 01772 270 570

 

back to RNS & Investor News

 

Latest Tweets Twitter

top